The Breast Biopsy Devices Market is being driven by Growing prevalence of breast cancer cases
The Breast Biopsy Devices Market is expected to grow at a CAGR of 10.87% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 778.7 million. The increasing trend towards minimally invasive procedures for breast cancer screening has fueled the demand for advanced breast biopsy devices. Businesses in this sector are responding by investing in technologically superior solutions, such as robotic platforms, surgical navigation systems, and artificial intelligence. These innovations aim to enhance the accuracy and efficiency of surgical procedures, reducing complications and human error. Traditional methods, including hand-held needles and imaging-guidance systems, can lead to inaccurate results due to human error. Notably, researchers at the University of Twente (Netherlands) have developed the MRI-safe Sunram 5, a robotic system for breast biopsy, which is set to revolutionize the industry.
Get more information on Breast Biopsy Devices Market by requesting a sample report
The market is segmented based on
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Market Scope |
|
Report Coverage |
Details |
Page number |
201 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 10.87% |
Market growth 2024-2028 |
USD 778.7 million |
Market structure |
market_structure.ucfirst |
YoY growth 2023-2024(%) |
9.53 |
Key countries |
US, Germany, France, China, and Canada |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
In the realm of breast cancer diagnostics, the Breast Biopsy Devices Market encompasses a range of tools used for obtaining biopsy samples during breast cancer screening. With the increasing incidence of breast cancer and subsequent deaths caused by invasive and premalignant breast conditions, there is a growing demand for advanced biopsy devices. These include needle breast biopsies and surgical breast biopsies, as well as emerging liquid breast biopsy technologies. Reimbursements, therapy selection, treatment monitoring, and recurrence monitoring are key factors driving market growth. The market caters to various end-users such as surgical centers, hospitals, research laboratories, pharmaceutical and biotechnology companies, and laboratory supplies providers. Early cancer diagnosis and improved treatment accessibility are primary benefits of these devices.
In the healthcare sector, Technavio identifies the Breast Biopsy Devices Market as a significant segment within the expansive Global Healthcare Equipment Market. This market encompasses entities involved in the research and development (R&D) of various diagnostic tools and devices, primarily focusing on capital equipment, instruments, implants, accessories, and consumables utilized for breast cancer screening and treatment. The global healthcare equipment market's size is determined by the collective revenue generated by manufacturers of diagnostic equipment and devices spanning diverse therapy areas. The healthcare equipment industry is segmented into Devices, which includes advanced, differentiated, and clinically tested data-driven devices used for breast cancer diagnosis, monitoring, and treatment. The Breast Biopsy Devices Market holds significance due to the increasing incidence of breast cancer, resulting in a substantial number of deaths caused by invasive breast cancers and premalignant breast conditions.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted